Madam Speaker, initially the NDP opposed CETA and we had many concerns, whether the investor-state dispute settlement mechanisms or the increased cost of drugs that patent protection for pharmaceutical companies would create. One thing we know is that CETA is widely understood to put upward pressure on the cost of pharmaceutical drugs.
Why are the Liberals entrenching these same provisions in yet another trade agreement while dragging their heels on delivering a national pharmacare plan?